VENLO, Netherlands & HILDEN, Germany–(BUSINESS WIRE)–$QGEN#QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction.
